Artelo Biosciences (ARTL) Cash & Equivalents (2014 - 2025)
Artelo Biosciences (ARTL) posted Cash & Equivalents of $600,000 for Q4 2025, down 74.3% from $2.34 million a year earlier and down 65.1% from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Cash & Equivalents (2014 - 2025) Analysis & Trends
Since Q3 2014, Artelo Biosciences has reported Cash & Equivalents for 46 quarters.
- Annual Cash & Equivalents has declined for four consecutive years, with a five-year compound annual growth rate of -22.5% (FY2020 to FY2025).
- In prior years, Artelo Biosciences' Cash & Equivalents was $2.34 million in FY2024 (-16.9%), $2.82 million in FY2023 (-59.1%), $6.89 million in FY2022 (-43.4%) and $12.16 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Cash & Equivalents since Q3 2019.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 19.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 685.8%; the weakest was Q2 2024, with a decline of 84.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $1.72 million (Q3 2025), $2.07 million (Q2 2025) and $746,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Artelo Biosciences | 73,320.32 | -5.06 Mn | - | 600,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 881,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 6.92 Mn |
| Dec 31, 2022 | 6.89 Mn |
| Sep 30, 2022 | 7.14 Mn |
| Jun 30, 2022 | 12.12 Mn |
| Mar 31, 2022 | 10.35 Mn |
| Nov 30, 2021 | 14.05 Mn |
| Aug 31, 2021 | 6.63 Mn |
| May 31, 2021 | 10.05 Mn |
| Feb 28, 2021 | 10.71 Mn |
API Access
Artelo Biosciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();